Advertisement
Advertisement
SOLV
Solventum Corporation
90.38
USDSponsored
+3.20
+3.67%
Nov 06, 15:59 UTC -5
Closed
After-Market
88.75
-1.63
-1.80%
Solventum Corporation (SOLV) Earnings
SOLV Earnings Reports
Positive Surprise Ratio
SOLV beat 11 of 11 last estimates.
100%
Next Report
Date of Next Report
Feb 24, 2027
Estimate for Q4 26 (Revenue/ EPS)
$2.13B
/$1.82
Implied change from Q3 26 (Revenue/ EPS)
+9.28%
/+25.52%
Implied change from Q4 25 (Revenue/ EPS)
+6.60%
/+15.92%
Solventum Corporation earnings per share and revenue
On Nov 05, 2026, SOLV reported earnings of 1.45 USD per share (EPS) for Q3 26, beating the estimate of 1.38 USD, resulting in a 5.02% surprise. Revenue reached 1.95 billion, compared to an expected 1.97 billion, with a -1.27% difference. The market reacted with a +3.67% price change (close before vs. close after earnings).
Looking ahead to Q4 26, 10 analysts forecast an EPS of 1.82 USD, with revenue projected to reach 2.13 billion USD, implying an increase of 25.52% EPS, and increase of 9.28% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Natera, Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.29
Actual
-$0.39
Surprise
-30.65%
Viatris Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
$0.64
Actual
$0.71
Surprise
+9.31%
Concentra Group Holdings Parent, Inc.
Report Date
Nov 05, 2026 For Q3 26
Estimate
$0.44
Actual
$0.52
Surprise
+16.88%
Sonida Senior Living, Inc.
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.54
Actual
-$0.65
Surprise
-19.11%
Nutex Health Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
$5.82
Actual
$5.71
Surprise
-1.93%
Omada Health, Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
$0.01
Actual
$0.17
Surprise
+900.00%
CryoPort, Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.17
Actual
-$0.25
Surprise
-38.97%
Shoulder Innovations, Inc.
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.50
Actual
-$0.34
Surprise
+32.57%
Biodesix, Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.76
Actual
-$0.75
Surprise
+1.77%
SkinHealth Systems Inc. Class A Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$1.30
Actual
-$0.14
Surprise
+89.28%
FAQ
What were Solventum Corporation's earnings and revenue for the latest quarter Q3 2026?
For Q3 2026, Solventum Corporation reported EPS of $1.45, beating estimates by 5.02%, and revenue of $1.95B, -1.27% below expectations.
How did the market react to Solventum Corporation's Q3 2026 earnings?
The stock price moved up 3.67%, changed from $87.18 before the earnings release to $90.38 the day after.
When is Solventum Corporation expected to report next?
The next earning report is scheduled for Feb 24, 2027.
What are the forecasts for Solventum Corporation's next earnings report?
Based on 10
analysts, Solventum Corporation is expected to report EPS of $1.82 and revenue of $2.13B for Q4 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.